Are you Dr. Ram?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 2 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000- Is this information wrong?
Summary
- Dr. Ron Ram, MD is a hematologist in Seattle, Washington.
Clinical Trials
- Telomerase Activity as a Marker For Mobilization Quality Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 3 citationsAllogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience.Dai Chihara, Luuk Gras, Nienke Zinger, Nicolaus Kröger, Jiri Mayer, Jakob Passweg, Régis Peffault De Latour, Jenny Byrne, William Krüger, Jan-Paul Bohn, Uwe Platzbecke...> ;Haematologica. 2023 Jun 1
- Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population.Tal Freund, Sarah K Baxter, Tom Walsh, Hana Golan, Joseph Kapelushnik, Michal Abramsohn-Goldenberg, Shira Benor, Nadav Sarid, Ron Ram, Yifat Alcalay, Reeval Segel, Pau...> ;Journal of Clinical Immunology. 2023 Jan 1
- 20 citationsToxicity and efficacy of chimeric antigen receptor T-cell in patients with diffuse large B cell lymphoma above the age of 70 years compare to younger patients - a matc...Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Odelia Amit, Yaeli Bar-On, Polina Stepensky, Moshe Yeshurun, Batia Avni, David Hagin, Chava Perry, Ronit Gurion, Nadav Sar...> ;Haematologica. 2021 Jul 8
- Join now to see all
Press Mentions
- Pluristem Announces Clearance to Move Forward with Enrollment for Cohort II in an Investigator-Led Phase I/II Chronic Graft vs Host Disease StudyOctober 13th, 2020
Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chronic GvHDNovember 6th, 2017
